Does VENLAFAXINE Cause Product packaging quantity issue? 7 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product packaging quantity issue have been filed in association with VENLAFAXINE (Venlafaxine Hydrochloride). This represents 0.0% of all adverse event reports for VENLAFAXINE.
7
Reports of Product packaging quantity issue with VENLAFAXINE
0.0%
of all VENLAFAXINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From VENLAFAXINE?
Of the 7 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENLAFAXINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does VENLAFAXINE Cause?
Drug ineffective (5,408)
Toxicity to various agents (3,917)
Nausea (2,989)
Completed suicide (2,929)
Headache (2,668)
Dizziness (2,426)
Off label use (2,310)
Overdose (2,220)
Intentional overdose (2,187)
Fatigue (2,153)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which VENLAFAXINE Alternatives Have Lower Product packaging quantity issue Risk?
VENLAFAXINE vs VENTAVIS
VENLAFAXINE vs VENTOLIN
VENLAFAXINE vs VENTOLIN HFA
VENLAFAXINE vs VERAPAMIL
VENLAFAXINE vs VERICIGUAT